Depression Vs. Dementia: How Do We Assess?
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
2020 Question Book
2020 QUESTION BOOK 13TH EDITION WHO WE ARE Welcome to the thirteenth edition of the Ninja’s Guide to PRITE! Loma Linda University Medical Center is located in sunny Southern California. about 60 miles east of Los Angeles. A part of the Adventist Health System, we provide patient care in one of the largest non-profit health systems in the nation. Loma Linda's mission is to excel in medical education, global healthcare, and community outreach, all under a central tenant: "To Make Man Whole." At the Loma Linda Department of Psychiatry, our residents are trained in many diverse patient care settings. As an official World Health Organization Collaboration Center, our department funds resident electives in Global Mental Health at locations around the world. Additionally, our residents can participate in national and international disaster relief on the LLU Behavioral Health Trauma Team. We were proud to welcome our first group of Child and Adolescent Psychiatry fellows in the Summer of 2019 and work collaboratively with 3 other residency programs within the region. Our residency didactic education is constantly evolving based upon resident feedback, and our residents have the opportunity to aid in course development. More than anything, our residency fosters an environment where residents and faculty treat each other like family. Our faculty are dedicated to resident education and professional development. We believe in "taking 'No' off the table", encouraging innovative change, and passionately supporting our residents to achieve anything they set their minds to. For over a decade our residents have volunteered their time to create The Ninja's Guide to PRITE at our Annual Ninja PRITE Workshop. -
Theory of Mind Deficit in the Behavioral Variant of Frontotemporal Dementia and in Amyotrophic Lateral Sclerosis: Why Does It Matter?
Open Access Journal of Neurology & Neurosurgery Editorial Open Access J Neurol Neurosurg Volume 1 Issue 1 - December 2015 Copyright © All rights are reserved by Marco Cavallo Theory of Mind deficit in the behavioral variant of frontotemporal dementia and in amyotrophic lateral sclerosis: Why does it matter? Marco Cavallo1,2* 1eCampus University, Novedrate (Como), Italy 2Mental Health Department - Azienda Sanitaria Locale Torino 3, Italy Submission: November 15, 2015; Published: December 02, 2015 *Corresponding author: Marco Cavallo, Neuropsychologist, Researcher at the faculty of Psychology of the eCampus University of Novedrate, Italy, Tel no: +39.3478306430; Email: Editorial stories that explicitly referred to social situations. Our results underlined the needs for further research to gain a deeper Theory of Mind (hereinafter referred to as ToM) is the ability understanding on the possible link between patient’s behavioral to explain and predict other people’s behavior by attributing problems and their limited understanding of social situations. independent mental states to them. It allows us to recognize that mental states such as beliefs, intentions, and desires play a key role in driving and monitoring human behavior. Impairment in associated with ALS, a neurodegenerative disease that from We also aimed at clarifying the nature of the ToM deficits ToM ability can be highly disabling. ToM had been extensively cognitive and neuroimaging points of view appears to share studied in neuropsychiatric conditions such as autism and some relevant -
Social Behaviour Vs. Psychiatric Features Of
Psychiatria Danubina, 2010; Vol. 22, No. 2, pp 179–182 Case report © Medicinska naklada - Zagreb, Croatia SOCIAL BEHAVIOUR VS. PSYCHIATRIC FEATURES OF FRONTOTEMPORAL DEMENTIA Clinical report of two cases Rajka Marija Liščić1 & Aleš Kogoj2 1Institute for Medical Research and Occupational Health, Zagreb, Croatia 2Department of Geriatric Psychiatry, University Psychiatric Hospital, Ljubljana, Slovenia received: 6.10.2009; revised: 12.1.2010; accepted: 9.2.2010 SUMMARY Behavioural disturbances are prominent in frontotemporal dementia (FTD), a focal, non-Alzheimer type of dementia. Although most patients with FTD present with socially inappropriate behaviour, compulsive-like acts, poor insight and disinhibition, the presence of psychiatric features including delusions, hallucinations, and paranoia can lead to a misclassification of FTD as psychiatric disorder. In the absence of cognitive deficits non-experts fail to recognize these social changes as dementia symptoms. We report two individuals who met current clinical criteria for behavioural or frontal variant FTD (bv-FTD), with the aim of distinguishing between psychotic symptoms and the often bizarre personality and behaviour change found in FTD. Also we review the literature on the noncognitive neuropsyhiatric manifestation of this disorder. Clinical findings presented, and a literature review, indicate that psychotic symptoms are rare in FTD. Better awareness of behavioural symptoms in clinical practice is necessary in order to avoid misdiagnosis of FTD as psychiatric disorder. Key words: bv-frontotemporal dementia - behavioural disturbances - psychotic symptoms * * * * * INTRODUCTION and paranoia) must be distinguished from the often bizarre personality and behaviour changes of FTD. The With baby boomers now reaching late middle age, overlap between FTD and psychotic symptoms exists degenerative diseases are becoming an increasingly and therefore may lead to misleading diagnoses. -
Relationship Between the Postoperative Delirium And
Theory iMedPub Journals Journal of Neurology and Neuroscience 2020 www.imedpub.com Vol.11 No.5:332 ISSN 2171-6625 DOI: 10.36648/2171-6625.11.1.332 Relationship Between the Postoperative Delirium and Dementia in Elderly Surgical Patients: Alzheimer’s Disease or Vascular Dementia Relevant Study Jong Yoon Lee1*, Hae Chan Ha2, Noh June Mo2, Hong Kyung Ho2 1Department of Neurology, Seoul Chuk Hospital, Seoul, Korea. 2Department of Orthopedic Surgery, Seoul Chuk Hospital, Seoul, Korea. *Corresponding author: Jong Yoon Lee, M.D. Department of Neurology, Seoul Chuk Hospital, 8, Dongsomun-ro 47-gil Seongbuk-gu Seoul, Republic of Korea, Tel: + 82-1599-0033; E-mail: [email protected] Received date: June 13, 2020; Accepted date: August 21, 2020; Published date: August 28, 2020 Citation: Lee JY, Ha HC, Mo NJ, Ho HK (2020) Relationship Between the Postoperative Delirium and Dementia in Elderly Surgical Patients: Alzheimer’s Disease or Vascular Dementia Relevant Study. J Neurol Neurosci Vol.11 No.5: 332. gender and CRP value {HTN, 42.90% vs. 43.60%: DM, 45.50% vs. 33.30%: female, 27.2% of 63.0 vs. male 13.8% Abstract of 32.0}. Background: Delirium is common in elderly surgical Conclusion: Dementia play a key role in the predisposing patients and the etiologies of delirium are multifactorial. factor of POD in elderly patients, but found no clinical Dementia is an important risk factor for delirium. This difference between two subgroups. It is estimated that study was conducted to investigate the clinical relevance AD and VaD would share the pathophysiology, two of surgery to the dementia in Alzheimer’s disease (AD) or subtype dementia consequently makes a similar Vascular dementia (VaD). -
Vascular Dementia Vascular Dementia
Vascular Dementia Vascular Dementia Other Dementias This information sheet provides an overview of a type of dementia known as vascular dementia. In this information sheet you will find: • An overview of vascular dementia • Types and symptoms of vascular dementia • Risk factors that can put someone at risk of developing vascular dementia • Information on how vascular dementia is diagnosed and treated • Information on how someone living with vascular dementia can maintain their quality of life • Other useful resources What is dementia? Dementia is an overall term for a set of symptoms that is caused by disorders affecting the brain. Someone with dementia may find it difficult to remember things, find the right words, and solve problems, all of which interfere with daily activities. A person with dementia may also experience changes in mood or behaviour. As the dementia progresses, the person will have difficulties completing even basic tasks such as getting dressed and eating. Alzheimer’s disease and vascular dementia are two common types of dementia. It is very common for vascular dementia and Alzheimer’s disease to occur together. This is called “mixed dementia.” What is vascular dementia?1 Vascular dementia is a type of dementia caused by damage to the brain from lack of blood flow or from bleeding in the brain. For our brain to function properly, it needs a constant supply of blood through a network of blood vessels called the brain vascular system. When the blood vessels are blocked, or when they bleed, oxygen and nutrients are prevented from reaching cells in the brain. As a result, the affected cells can die. -
Antipsychotic Medication Reduction
So tonight we'll be discussing antipsychotic medication reduction. I'm happy to share some of my experiences with this challenging initiative and in nursing homes. I have no financial affiliations to disclose. And for our objectives and our agenda today, we're going to assess and evaluate appropriate antipsychotic medication use in nursing home residents, and apply strategies toward behavior management and antipsychotic medication reduction. The first part of the program we'll look at current trends and rates of antipsychotic medication use. We'll discuss the CMS initiative and latest policy issues. And then we'll look at a couple case studies. So first off, this first graph goes over the national progress in reducing the inappropriate use of antipsychotic medications in nursing homes. The taller red bar gives us the 2011 baseline number of 23.9%. That's a dotted red line indicates the start of the 2012 CMS initiative. That's the National Partnership to Improve Dementia Care in Nursing Homes. The latest information all the way down at the end is from the third quarter of 2018, which shows that nationally we have a 14.6% use rate. Overall, this looks like a reduction of nearly 40% since the initiative began. Overall though, I think this is great progress. Why should we be concerned with antipsychotic medications at all in this population? I have to say, that when I first exited my training from psychiatry and geriatric psychiatry, the black box warning had not yet come out. And it hit me that most of all the training that I learned was getting reversed when I entered the care setting. -
A Patient's Guide to Parkinson's Disease Dementia (PDD)
A Patient’s Guide to Parkinson’s Disease Dementia (PDD) This material is provided by UCSF Weill Institute for Neurosciences as an educational resource for patients. Models for illustrative purposes only. A patient’s guide to Parkinson’s Disease Dementia (PDD) What is dementia? eventually parts of the brain that are important for mental functions such as memory and thinking become injured. Dementia is a general term for any disease that causes a change in memory and/or thinking skills that is severe enough to impair How is age related to PDD? a person’s daily functioning. Symptoms of dementia vary from Both PD and PDD are more common with increasing age. Most person to person and may affect one’s ability to remember things, people with PD start having movement symptoms between ages concentrate, plan and organize, communicate or find one’s way 50 and 85, although some people have shown signs earlier. Up to around, among other possible symptoms. There are many causes 80% of people with PD eventually develop dementia. The average of dementia and Parkinson’s disease can be one of them. Not at all time from onset of movement problems to development people with Parkinson’s disease develop dementia. of dementia is about 10 years. What is Parkinson’s disease dementia? What happens in PDD? Parkinson’s disease dementia (PDD) is changes in thinking and People with PDD may have trouble focusing, remembering things, behavior in someone with a diagnosis of Parkinson’s disease (PD). or making sound judgments. They may develop depression, anxiety PD is an illness characterized by gradually progressive problems or irritability. -
Mild Cognitive Impairment Or Dementia
What To Know When You Have Mild Cognitive Impairment or Dementia People who are told they have mild cognitive impairment (MCI) experience symptoms that are similar to dementia, but aren’t as serious. People with MCI have changes in memory or thinking typically poorer than would be expected for someone their age, but the changes don’t interfere with daily activities. It should be noted that people with MCI have a higher risk of developing dementia, but not all will. Dementia is an umbrella term to describe symptoms that are severe enough to interfere with daily activities. The most common cause of dementia in older adults is Alzheimer’s disease. Other causes include Lewy body dementia, vascular dementia and Frontotemporal diseases. A diagnosis of Alzheimer’s disease or a related disorder doesn’t change who you are and it doesn’t mean you need to stop doing things you find meaningful. It does mean that over time you might have to do them in a different way or have some assistance. The disease does not affect the entire brain all at once. Many areas of the brain are not affected, or are affected much later. Important Messages Dementia can affect memory, We All Should Know thinking, communication and doing everyday tasks. Dementia is not a natural part of aging. It’s possible to live well with dementia. Dementia is caused by diseases of the brain and will There is more to a person affect each person differently. than the dementia. Ways to Work With Mild Cognitive Impairment or Dementia 1 6 Stop multi-tasking. -
When the Mind Falters: Cognitive Losses in Dementia
T L C When the Mind Falters: Cognitive Losses in Dementia by L Joel Streim, MD T Associate Professor of Psychiatry C Director, Geriatric Psychiatry Fellowship Program University of Pennsylvania VISN 4 Mental Illness Research Education and Clinical Center Philadelphia VA Medical Center Delaware Valley Geriatric Education Center The goal of this module is to teach direct staff about the syndrome of dementia and its clinical effects on residents. It focuses on the ways that the symptoms of dementia affect persons’ functional ability and behavior. We begin with an overview of the symptoms of cognitive impairment. We continue with a description of the causes, epidemiology, and clinical course (stages) of dementia. We then turn to a closer look at the specific areas of cognitive impairment, and examine how deficits in different areas of cognitive function can interfere with the person’s daily functioning, causing disability. The accompanying videotape illustrates these principles, using the example of a nursing home resident whose cognitive impairment interferes in various ways with her eating behavior and ability to feed herself. 1 T L Objectives C At the end of this module you should be able to: Describe the stages of dementia Distinguish among specific cognitive impairments from dementia L Link specific cognitive impairments with the T disabilities they cause C Give examples of cognitive impairments and disabilities Describe what to do when there is an acute change in cognitive or functional status Delaware Valley Geriatric Education Center At the end of this module you should be able to • Describe the stages of dementia. These are early, middle and late, and we discuss them in more detail. -
APA Patient and Caregiver Guide: Antipsychotic Medications to Treat
PATIENT AND CAREGIVER GUIDE: Antipsychotic Medications to Treat Agitation or Psychosis in Adults with Dementia OVERVIEW Dementia—a group of symptoms that includes memory loss, confusion, and trouble with problem-solving that is severe enough to disrupt daily life—affects over 5 million Americans, particularly those age 65 and older. Many people living with dementia can develop agitation or psychosis. These symptoms may come and go or last for longer periods of time. They can be stressful and possibly dangerous for the people living with dementia and their caregivers. If these symptoms are not treated, families may have a harder time providing care and the person living with dementia may ultimately need long-term care. Treating agitation and psychosis can improve the quality of life for people living with dementia and provide some relief to their caregivers. This guide provides information about the causes of agitation and psychosis in adults living with dementia and available treatment options. It can help patients and families begin the discussion with their doctor to make an informed decision about appropriate treatment. The patient and caregiver guide is based on the practice guideline the American Psychiatric Association (APA) published in 2016 for psychiatrists and other health professionals. The complete guideline, The Use of Antipsychotics to Treat Agitation or Psychosis in Patients with Dementia, is available from APA Publishing, along with more information about how it was developed. KEY TERMS Dementia Agitation A group of symptoms, including memory loss, confusion, A state of excessive physical movement, verbal and trouble with problem solving or finding words, that aggression, or physical aggression to oneself or others is severe enough to disrupt daily life due to a decline in that is associated with emotional distress. -
Alzheimer's Disease
Evaluation of Cognitive Decline in a Person with Intellectual and Developmental Disabilities Changing US Population Demographics Aging and Intellectual and Developmental Disabilities ●In 2002, an estimated 641,000 adults with IDD were older than 60. ●In 2002 about 75% of all older adults with IDD were in the 40-60 year old age range. ●The number of adults with IDD age 60 years and older is projected to nearly double from 641,860 in 2000 to 1.2 million by 2030 due to increasing life expectancy and the aging of the baby boomer generation Carter & Jancar, 1983, Janicki, Dalton, Henderson, & Davidson, 1999 . Currently estimated life expectancy of a . 25% of persons with Down 1-year-old child with DS is between 43 syndrome are still alive at 65 and 55 years years Curr Gerontol Geriatr Res. 2012; 2012: 412-536. Rubin & Crocker,2006; Yang Rasmussen & Friedman, 2002 Expected Physical Changes of Aging ●Osteopenia/Osteoporosis - normal aging-related bone loss ●Sarcopenia - progressive loss of muscle mass ●Presbyopia: the lens of the eye becomes stiffer and less flexible – affecting the ability to focus on close objects (accommodation) ●Presbycusis – aging related change in the ability to detect higher pitches – more noticeable in those age 50+ ●Gustation (i.e. the sense of taste) decrements become more noticeable beyond 60+ ●Olfaction (i.e. the sense of smell) decrements become more noticeable after age 70+ ●Somatosensory System - Reduction in sensitivity to pain, touch, temperature, proprioception ●Vestibular – Reduction in balance and coordination -
Psychotropic Medication Concerns When Treating Individuals with Developmental Disabilities
Tuesday, 2:30 – 4:00, C2 Psychotropic Medication Concerns when Treating Individuals with Developmental Disabilities Richard Berchou 248-613-6716 [email protected] Objective: Identify effective methods for the practical application of concepts related to improving the delivery of services for persons with developmental disabilities Notes: Medication Assistance On-Line Resources OBTAINING MEDICATION: • Needy Meds o Needymeds.com • Partnership for Prescriptions Assistance o Pparx.org • Patient Assistance Program Center o Rxassist.org • Insurance coverage & Prior authorization forms for most drug plans o Covermymeds.com REMINDERS TO TAKE MEDICATION: • Medication reminder by Email, Phone call, or Text message o Sugaredspoon.com ANSWER MOST QUESTIONS ABOUT MEDICATIONS: • Univ. of Michigan/West Virginia Schools of Pharmacy o Justaskblue.com • Interactions between medications, over-the-counter (OTC) products and some foods; also has a pictorial Pill Identifier: May input an entire list of medications o Drugs.com OTHER TRUSTED SITES: • Patient friendly information about disease and diagnoses o Mayoclinic.com, familydoctor.org • Package inserts, boxed warnings, “Dear Doctor” letters (can sign up to receive e- mail alerts) o Dailymed.nlm.nih.gov • Communications about drug safety o www.Fda.gov/cder/drug/drugsafety/drugindex.htm • Purchasing medications on-line o Pharnacychecker.com Updated 2013 Psychotropic Medication for Persons with Developmental Disabilities April 23, 2013 Richard Berchou, Pharm. D. Assoc. Clinical Prof., Dept. Psychiatry & Behavioral